ReviewNew microbes and new infections2025
Seroprevalence of tick-borne infections in blood donors in Europe: a systematic review.
Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reassessing Regional Tick-Borne Encephalitis Endemicity in Poland Through Seroprevalence Analysis in Blood Donors, 2021-2022.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tick-borne infections (TBIs) pose an increasing threat to public health and recent research shows a wide range of infections transmitted to humans by tick bite. This situation may have an impact on blood safety in the context of transfusion-transmitted TBIs. We aimed to assess the seroprevalence of TBIs in blood donors in Europe in the period 2000 to 2024. Methods: This systematic review followed PRISMA guidelines. We searched PubMed, Embase, MEDLINE, Scopus, CINAHL, and national reporting systems up to April 2024 using keywords related to TBIs, Europe and epidemiology. Two reviewers independently screened and selected studies, focusing on seroprevalence of TBIs in European blood donors from 2000 to 2024. Data extraction and risk of bias assessment were performed. Results: The search yielded 5304 articles, of which 56 met the inclusion criteria. We added one article after citation search. The included studies encompassed 19 European countries and 11 different TBIs. The most studied pathogen was Conclusions: This study highlights the need to focus on a wider range of tick-borne pathogens to better understand the epidemiological landscape of TBIs. Additionally, incorporating Nucleic Acid Amplification Testing of donated blood will improve the ability to differentiate between past exposure and potential infectivity, to allow for an improved assessment of TBI transmission risk in transfusion medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.